Evidence-based pharmacotherapy for personality disorders
Authors:
Open Access
- 15 February 2011
- journal article
- review article
- Published by Oxford University Press (OUP) in International Journal of Neuropsychopharmacology
- Vol. 14 (09) , 1257-1288
Abstract
Patients with personality disorders are prescribed psychotropic medications with greater frequency than almost any other diagnostic group. PrescribinKeywords
This publication has 179 references indexed in Scilit:
- Pergolide Treatment of Cognitive Deficits Associated with Schizotypal Personality Disorder: Continued Evidence of the Importance of the Dopamine System in the Schizophrenia SpectrumNeuropsychopharmacology, 2010
- Topiramate Treatment of Women With Borderline Personality Disorder, Part IIJournal of Clinical Psychopharmacology, 2008
- World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Personality DisordersThe World Journal of Biological Psychiatry, 2007
- Blunted Hormone Responses to Ipsapirone are Associated with Trait Impulsivity in Personality Disorder PatientsNeuropsychopharmacology, 2005
- Elevated triiodothyronine in psychopathy ? possible physiological mechanismsJournal of Neural Transmission, 2004
- Borderline Personality, Opioids, and NaltroxoneHeadache: The Journal of Head and Face Pain, 2000
- d,l-fenfluramine Response in Impulsive Personality Disorder Assessed with [18F]fluorodeoxyglucose Positron Emission TomographyNeuropsychopharmacology, 1999
- Brofaromine for Social PhobiaJournal of Clinical Psychopharmacology, 1997
- Moclobemide in Social PhobiaJournal of Clinical Psychopharmacology, 1997
- Moclobemide in social phobiaEuropean Archives of Psychiatry and Clinical Neuroscience, 1997